The AKT1/NFκB signaling pathway in CML cells is abnormally activated, which inhibits apoptosis and promotes malignant proliferation of CML cells [17]. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.